T80.A19 Non-ABO incompatibility with hemolytic transfusion reaction, unspecified

Name of the Condition

• Non-ABO incompatibility with hemolytic transfusion reaction, unspecified.

Summary

This condition describes a hemolytic transfusion reaction resulting from non-ABO blood group incompatibility, where the specific timing or clinical details are not further specified. It occurs when the recipient’s immune system reacts to non-ABO antigens in transfused blood or blood products, leading to the destruction of red blood cells and associated clinical manifestations. The reaction is characterized by immune-mediated hemolysis, which may present with varying severity depending on the extent of antigen mismatch and the recipient’s immune response.

Causes

Non-ABO incompatibility with hemolytic transfusion reactions can arise from immune responses to minor blood group antigens, such as Rh, Kell, Duffy, or Kidd systems, or antibodies against platelet or plasma proteins. These reactions may be triggered by prior sensitization through pregnancy, previous transfusions, or organ transplants, where the recipient has developed antibodies against these antigens. The reaction occurs when incompatible blood is transfused, leading to complement activation and red blood cell lysis.

Risk Factors

• Prior exposure to incompatible blood products
• History of multiple transfusions or pregnancies
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or flushing)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Hemolysis (evidenced by dark urine or jaundice)
• Back pain or flank pain
• Nausea or vomiting

Diagnosis

Diagnosis involves clinical evaluation of symptoms following a transfusion, laboratory testing to confirm hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and identification of non-ABO antibodies in the recipient’s serum. Crossmatching and antibody screening may help determine the specific antigen involved. Imaging or additional tests may be used to assess complications like renal impairment or disseminated intravascular coagulation (DIC).

Treatment Options

Treatment focuses on stopping the transfusion immediately, providing supportive care (e.g., fluids, oxygen), and managing symptoms such as fever or hypotension. Severe cases may require interventions like dialysis for renal failure or blood pressure support. Corticosteroids or other immunosuppressants may be used in select cases, and further transfusions must be carefully matched to avoid repeat reactions.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Mild cases often resolve with supportive care, while severe reactions can lead to significant morbidity or mortality. Follow-up includes monitoring for delayed complications (e.g., renal dysfunction) and ensuring future transfusions are compatible. Long-term management may involve antibody screening and specialized blood product selection.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multiorgan failure
• Recurrent hemolytic episodes with subsequent transfusions
• Long-term immune sensitization

Lifestyle & Prevention

Prevention involves thorough pre-transfusion testing, including antibody screening and crossmatching, especially in patients with prior transfusions or pregnancies. Using leukoreduced or antigen-matched blood products may reduce risk. Patients with a history of reactions should carry medical alerts and work with healthcare providers to plan future transfusions.

When to Seek Professional Help

Seek immediate medical attention if symptoms like fever, chills, shortness of breath, or dark urine occur during or after a transfusion. Prompt evaluation is critical to prevent severe complications. Follow up with a healthcare provider if symptoms persist or new issues arise after discharge.

Tips for Medical Coders

Document the clinical context of the transfusion reaction, including timing (acute vs. delayed) and specific symptoms, to support the unspecified nature of this code. Ensure documentation confirms non-ABO incompatibility and hemolysis, as these are key to accurate coding. Note any additional details (e.g., organ involvement) that may affect coding specificity, though this code is intended for cases where such details are not further specified.